<?xml version="1.0" encoding="UTF-8"?>
<p id="Par73">Ongoing protocols of such passive immunization strategies are in recruitment phase around the world. The US FDA approved the use of plasma from recovered patients to treat people who are critically ill with COVID-19, provided that doctors get approval over the telephone.</p>
